𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.

✍ Scribed by van Engelen, B G; Miller, D J; Pavelko, K D; Hommes, O R; Rodriguez, M

Book ID
124087152
Publisher
BMJ Publishing Group
Year
1994
Tongue
English
Weight
837 KB
Volume
57
Category
Article
ISSN
0022-3050

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Experimental strategies to promote centr
Experimental strategies to promote central nervous system remyelination in multiple sclerosis: Insights gained from the Theiler's virus model system
✍ D. J. Miller; K. Asakura; Dr. M. Rodriguez πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 640 KB

The destruction of central nervous system (CNS) myelin, the lipid-rich insulator surrounding axons in the mammalian brain and spinal cord, is the primary pathological finding in multiple sclerosis. Myelin loss can result in a significant clinical deficit, and was originally thought to be permanent,

[Current Topics in Microbiology and Immu
[Current Topics in Microbiology and Immunology] Advances in multiple Sclerosis and Experimental Demyelinating Diseases Volume 318 || Remyelination in Experimental Models of Toxin-Induced Demyelination
✍ Rodriguez, Moses πŸ“‚ Article πŸ“… 2008 πŸ› Springer Berlin Heidelberg 🌐 German βš– 582 KB

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people